Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
about
Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma.Induction of c-Met proto-oncogene by Epstein-Barr virus latent membrane protein-1 and the correlation with cervical lymph node metastasis of nasopharyngeal carcinomaEpstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma.Immunohistochemical expression of latent membrane protein 1 (LMP1) and p53 in nasopharyngeal carcinoma: Moroccan experience.Nasopharyngeal carcinoma: alternative treatment options after disease progression.The pathological roles of BART miRNAs in nasopharyngeal carcinoma.Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53.Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells.Association of latent membrane protein 1 and matrix metalloproteinase 9 with metastasis in nasopharyngeal carcinoma.Tumor-specific cytolysis caused by an E1B55K-attenuated adenovirus in nasopharyngeal carcinoma is augmented by cisplatin.High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?Hepatitis C virus-NS3P in relation to p53, p21waf, mdm2, p21-ras and c-erbB2 in hepatocarcinogenesis.Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck.Heterogeneity of HLA and EBER expression in Epstein-Barr virus-associated nasopharyngeal carcinoma.
P2860
Q35045601-EDA3F2B1-CE5D-4EB9-8612-983FD9905BFBQ35746620-0100FDE7-E799-42D8-920C-04A0F7FE4E60Q36613732-72E9BBDB-4A4D-472D-8303-F58B621DC6EAQ37299057-17A9C84E-4EB7-4B1B-808E-343767CFBFFAQ37705415-19C12645-29F1-4F52-9622-30145CFDF60AQ37995110-231B9A44-D061-45BB-9F50-00246424C35BQ38309880-85DBE05C-973B-4BFA-80E8-95D180897D0FQ39333947-88DAA1AD-8BD2-4420-BD53-13BD70EA063DQ40547103-3A5CF65F-2AA4-44E5-AECA-771570C8AA76Q40860124-168677BE-AAE3-4DCE-A24E-59F5924ADD9EQ42261523-13B256EA-0466-4518-A31A-CB8EB21120DCQ42491304-C44E1310-8C44-4912-8DD0-74871648C402Q45423117-DEFBB6C6-ABAF-4A3B-B9D9-90D200A9401CQ45732745-06B8E3AB-0CDA-413E-BBD5-65BDD0D38EC0Q45736565-5617F819-16C5-480E-9E4F-60BBF416B9EEQ45739568-E9861EEC-07DE-467F-B50F-13E4895E3D63
P2860
Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Association of Epstein-Barr vi ...... n in nasopharyngeal carcinoma.
@en
type
label
Association of Epstein-Barr vi ...... n in nasopharyngeal carcinoma.
@en
prefLabel
Association of Epstein-Barr vi ...... n in nasopharyngeal carcinoma.
@en
P2093
P2860
P1433
P1476
Association of Epstein-Barr vi ...... n in nasopharyngeal carcinoma.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2559.1999.00625.X
P577
1999-05-01T00:00:00Z